Research Article
Comparison of International Normalized Ratio Measurement between CoaguChek XS Plus and STA-R Coagulation Analyzers
Table 2
Previous studies on the performances of CoaguChek XS Plus system.
| Study | Number of measurements | Setting | Laboratory-based system | Comparison using Bland-Altman plot, mean bias (95% limit of agreement) |
| Deom et al. (2009) [13] | 259 | Community setting (38 doctor’s offices) | Innovin (Siemens/Dade-Behring) | 0.03 INR (−0.67 INR ~ 0.74 INR) | Urwyler et al. (2009) [14] | 227 | Perioperative setting | Innovin (Siemens/Dade-Behring) | 2.3% (95% CI = −20.3% ~ 24.9%) | Donaldson et al. (2010) [10] | 52 | Pharmacist-managed anticoagulation clinic | Stago (Diagnostica-stago) | 0.27 INR (−0.33 INR ~ 0.88 INR) |
Celenza and Skinner (2011) [15] | 293 | Emergency department | Not specified | −0.0 INR (−1.1 INR ~ 1.1 INR) | Lawrie et al. (2012) [16] | 168 for innovin and 115 for PT-Fib HS+ | Overanticoagulated (INR > 4.5) patients in anticoagulation clinic | Innovin (Siemens/Dade-Behring) on CA-7000 analyzer (Sysmex) and PT-Fib HS+ (Instrumentation Laboratory) on CA-1500 analyzer (Sysmex) | Innovin: −0.1% (−22.0% ~ 22.1%) PT-Fib HS+: 8.2% (−21.4% ~ 37.9%) | Urwyler et al. (2012) [17] | 73 | Pediatric intensive care unit setting | Innovin (Siemens/Dade-Behring) | 1.22% (−27% ~ 56%) |
|
|
Abbreviations: INR: international normalized ratio; SD: standard deviation; CI: confidence interval; PT-Fib HS+: HemosIL PT-Fibrinogen HS Plus.
|